温阳利水汤对慢性肾心综合征患者的治疗效果

The therapeutic effect of wenyang lishui decoction on patients with chronic renal heart syndrome

目的探讨对慢性肾心综合征(CRCS)患者给予温阳利水汤治疗的临床疗效。方法选用本院2017年3月至2018年3月收治的86例CRCS患者进行观察,随机分组法将86例痰患者分为研究组、对照组各43例,对照组给予西医常规治疗,研究组在对照组基础上联合温阳利水汤治疗。治疗2个月,观察两组总有效率、生活质量(SF-36)评分、血肌酐(CRE)、血清B型尿钠肽(BNP)、尿素氮(BUN)水平、6 min步行试验结果。结果研究组总有效率、SF-36评分、6 min步行试验结果均优于对照组,差异有统计学意义(P<0.05);且研究组血清BNP、BUN及CRE水平均低于对照组(P<0.05)。结论对CRCS患者给予温阳利水汤治疗能有效改善患者肾功能,缓解畏寒肢冷、尿少、胸闷等症状,提高患者生活质量,疗效安全可靠。

Objective To investigate the clinical effect of wenyang lishui decoction on chronic renal heart syndrome(CRCS).Methods Selection in our hospital from March 2017 to March 2018 admitted to observe 86 patients of CRCS,86 patients with sputum were randomly divided into research group and the control group(n=43),the control group given conventional western medicine treatment,the research group in the control group on the basis of joint WenYangLi water decoction.In February,the total effective rate,quality of life(sf-36)score,serum creatinine(CRE),serum b-type natriuretic peptide(BNP),urea nitrogen(BUN)level and 6min walking test were observed.Results The total effective rate,sf-36 score and 6min walking test results of the study group were better than those of the control group,and the difference was statistically significant(P<0.05).The serum BNP,BUN and CRE levels of the study group were lower than those of the control group(P<0.05).Conclusion The treatment of CRCS patients with wenyang lishui decoction can effectively improve the renal function of patients,relieve the symptoms of chills,lack of urine and chest tightness,improve the quality of life of patients,and the efficacy is safe and reliable.